Iovance Biotherapeutics
IOVA
IOVA
243 hedge funds and large institutions have $3.88B invested in Iovance Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 88 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
4.17% less ownership
Funds ownership: 106.08% → 101.91% (-4.2%)
8% less capital invested
Capital invested by funds: $4.22B → $3.88B (-$332M)
Holders
243
Holding in Top 10
7
Calls
$50.3M
Puts
$30.6M
Top Buyers
| 1 | +$38.8M | |
| 2 | +$34.5M | |
| 3 | +$25.9M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$20.9M |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
+$12.6M |
Top Sellers
| 1 | -$160M | |
| 2 | -$32M | |
| 3 | -$31.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$24.1M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$22.6M |